This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Baker, G.B. Articles by Bornstein, R.A. Search for Related Content PubMed Articles by Baker, G.B. Articles by Bornstein, R.A. Social Bookmarking                         What's this?

Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: an update

Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Canada

P.R. Chokka

Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Canada

R.A. Bornstein

Department of Psychiatry, Ohio State University, Columbus, OH, USA

Neurochemical investigations of Tourette's syndrome (TS) suggest that the symptoms of this disorder may be the result of an imbalance among several neurotransmitter and/or neuromodulator systems. Neurochemicals which have been studied included: catecholamines; acetylcholine; tryptophan and its metabolites; the amino acids -aminobutyric acid (GABA), glutamate, phenylalanine and p-tyrosine; trace amines; opioid peptides; cyclic AMP and androgenic hormones. A suitable animal model of TS would do much to advance our understanding of this disorder, and there are some interesting recent developments in this regard.

Key Words: acetylcholine • amino acids • androgenic hormones • ß-phenylethylamine • catecholamines • cyclic AMP; dynorphin • kynurenine • serotonin • Tourette's syndrome • tryptamine • review

Journal of Psychopharmacology, Vol. 9, No. 3, 273-280 (1995)
DOI: 10.1177/026988119500900311


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?